NCT05304598View on ClinicalTrials.gov

Using Dexmedetomidine Prior to Intubation in Neonates

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 14, 2022

Primary Completion Date

August 20, 2024

Study Completion Date

August 20, 2024

Conditions
Effect Neonatal
Interventions
DRUG

Dexmedetomidine

a single intravenous (i.v.) dose of dexmedetomidine, 0.2 mcg/kg over 10 minutes

OTHER

Usual Care

routine awake intubation as per current unit standard of care,

Trial Locations (1)

11219

Maimonides Medical Center, Brooklyn

Sponsors
All Listed Sponsors
lead

Maimonides Medical Center

OTHER

NCT05304598 - Using Dexmedetomidine Prior to Intubation in Neonates | Biotech Hunter | Biotech Hunter